Insiders · Profile

Samaha Eli

10% owner at Theravance Biopharma · Director at Stagwell. Filing since 30 Nov 2021. CIK 0001877589

Company
Date
Role
Action
Shares
Amount
Of holding
1 Jul 2026
10% owner
Sold at will
37,799
$642.63K
0.4%
30 Jun 2026
10% owner
Sold at will
25,027
$428.79K
0.3%
29 Jun 2026
10% owner
Sold at will
273,871
$4.72M
2.9%
5 Jun 2025
Director
Bought
240,000
$1.06M
3.1%
4 Jun 2025
Director
Bought
425,757
$1.82M
5.8%
9 May 2025
Director
Bought
200,903
$956.32K
2.8%
7 Aug 2024
10% owner
Bought
999,800
$7.80M
11.7%
1 May 2024
10% owner
Bought
1,499,124
$13.12M
21.4%
10 Mar 2023
Director
Bought
750,000
$5.06M
11.7%
12 May 2022
Director
Bought
50,000
$344.79K
0.8%
11 May 2022
Director
Bought
556,846
$3.85M
9.6%
10 May 2022
Director
Bought
37,606
$255.45K
0.7%
6 Dec 2021
Director
Bought
290,296
$2.36M
5.3%
3 Dec 2021
Director
Bought
2,665
$20.92K
0.0%
2 Dec 2021
Director
Bought
115,000
$888.95K
2.2%
1 Dec 2021
Director
Bought
230,400
$1.77M
4.5%
30 Nov 2021
Director
Bought
104,600
$783.45K
2.1%
17 decisions on file.